Albert Camus: Philosophy of Absurdity and Revolt

My Socialist Hall of Fame

During this chaotic era of vile rhetoric and manipulative tactics from our so-called bourgeois leaders, I am invigorated by the opportunity to reflect on Socialists, Revolutionaries, Philosophers, Guerrilla Leaders, Partisans, and Critical Theory titans, champions, and martyrs who paved the way for us—my own audacious “Socialism’s Hall of Fame.” These are my heroes and fore-bearers. Not all are perfect, or even fully admirable, but all contributed in some way to our future–either as icons to emulate, or as warnings to avoid in the future.

Albert Camus: Philosophy of Absurdity and Revolt

Read More »

RFK Jr. Is Headlining the Rx and Illicit Drug Summit. This Doesn’t Bode Well.

RFK Jr. Is Headlining the Rx and Illicit Drug Summit. This Doesn’t Bode Well.

On April 21, the first day of the 14th annual Rx and Illicit Drug Summit, organizers announced a surprise presenter for the closing plenary on April 24: Robert F. Kennedy Jr., newly minted Secretary of the Department of Health and Human Services and vocal proponent of building labor camps for people who use drugs.

Read More »

Marxism and Psychological Science

1.1. The General Bases of Marxist Psychology

The teachings of Karl Marx caused a revolution in social sciences: in philosophy, in political economy, in the theory of socialism. As is known, psychology remained isolated from the influence of Marxism for many years. Marxism was not admitted into the official centers of scientific psychology, and the name of Karl Marx remained almost unmentioned in the works of psychologists for more than 50 years after the publication of his basic work.

Marxism and Psychological Science

Related:

Activity and Consciousness (PDF)

Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here’s What’s Next

Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here’s What’s Next

Yet one glaring problem remains. Despite promising clinical results, no one knows exactly how psychedelic drugs work in the brain. Examining their actions on brain cells isn’t just an academic curiosity. It could give rise to variants that maintain antidepressant properties without the high. And because hallucinogens substantially alter our perception [management?!] of the world, they could be powerful tools for investigating the neurobiology behind consciousness.

This year, scientists found another common themepsychedelics seem to “reset” the brain to a more youthful state, at least in mice. Like humans, mice have an adolescent critical period, during which their brains are highly malleable and can easily rewire neural circuits, but the window closes after adulthood.

An earlier study showed that MDMA reopens the critical window in adult mice, so that they change their “personality.” Mice raised alone are often introverted and prefer to keep to themselves in adulthood. A dose of MDMA increased their willingness to snuggle with other mice—essentially, they learned to associate socializing with happiness, concluded the study.

It’s not that surprising. MDMA is well-known to promote empathy and bonding. The new study, by the same team, extended their early results to four psychedelics that don’t trigger fuzzy feelings—LSD, ketamine, psilocybin, and ibogaine. Similar to MDMA, adult mice raised alone changed their usual preference for solitude when treated with any of the drugs. Because habits are hard to change in adulthood—for mice and men—the drugs may have reopened the critical period, allowing the brain to more easily rewire neural connections based on new experiences.

These are just early results. But psychedelic research is gaining a new ally—artificial intelligence. Algorithms that predict protein structure, combined with rational drug design, could generate psychedelics that retain their psychiatric benefits without the high.

H/T: The Most Revolutionary Act

Related:

Psychoanalytic roots of CIA psychoprofiling/pseudoscience

Meaghan thought psychedelic therapy could help her PTSD. Instead it was the start of a nightmare

Why is the American right suddenly so interested in psychedelic drugs

What if a Pill Can Change Your Politics or Religious Beliefs? (archived)

Do Psychedelic Trips Change Your Political Views? (archived)

FDA Weighs New Application To Approve MDMA As First-Ever Psychedelic Medicine For PTSD + More About MAPS

A psychedelics-focused drug development company is officially asking the Food and Drug Administration (FDA) to review an application to approve MDMA as a prescription medication for the treatment of post-traumatic stress disorder (PTSD).

The MAPS Public Benefit Corporation (MAPS PBC) announced on Tuesday that it submitted the new drug application (NDA) to FDA, requesting an expedited review given that the agency previously designated the psychedelic as a breakthrough therapy.

FDA Weighs New Application To Approve MDMA As First-Ever Psychedelic Medicine For PTSD

H/T: The Most Revolutionary Act

The MAPS Public Benefit Corporation is subsidiary of Multidisciplinary Association for Psychedelic Studies. MAPS was founded by Rick Doblin.*

Related:

Read More »